Banner
Banner
Calendar of Events
Calendar of Events
Monthly View
Monthly View
Flat View
Flat View
Categories
Categories
Search
Search
Print
Print
Event: 'Cancer Vaccines' Print
  Europe
Bio Conferences in Europe
Date: Wednesday, September 19, 2012 - 9:00 am
Contact Info:
General Enquiries: SMi Group Ltd, 2nd Floor South, Harling House, 47-51 Great Suffolk Street, London, SE1 0BS, United Kingdom. Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001 Client Services: Tel: +44 (0) 870 9090 711 Fax: +44 (0) 870 9090 712
Email:

overview

SMi is proud to present their inaugural conference...

Cancer Vaccines 2012

19th & 20th September 2012, London

 

About the Conference

SMi's inaugural conference on Cancer Vaccines will provide attendees with a complete view of the cancer immunotherapy field. Focusing on the discovery of new vaccines, developments in target identification and vaccine delivery strategies, this informative event will bring together key opinion leaders in the field to provide attendees with an indepth look into current advances in cancer vaccines.

The event will present itself as a perfect forum for learning about new advances in the field, presenting attendees with the latest information on technogical and regulatory updates in the field. SMi's Cancer Vaccines 2012 will explore the use of biomarkers in cancer immunotherapy developments and will provide the perfect platform for discussions into regulatory challenges faced in cancer developments as well as strategies to improve success in clinical trials.

With senior industry representatives presenting on their own exepriences and referring to case studies, success stories and failures, this event promises to be a unique forum for problem-solving debate and idea-sharing discussion.

Interested in speaking at the conference? Contact the Conference Producer.

For sponsorship and exhibition opportunitiesContact our Sponsorship Department


Why should you attend this event?

 

• Learn about and consider the issues within novel vaccine discovery

• Discuss methods and strategies for efficient target selection

• Consider developments in vaccine delivery strategies

• Understand the use of biomarkers in cancer immunotherapy

• Debate the importance of overcoming immune supression in the tumor microenvironment

Evaluate manufacturing, regulatory and commercial challenges

Develop ideas and network with key industry professionals


Hear keynote addresses from:

Our Expert Speaker Line-up includes:

Vincent Brichard, Senior Vice President, GSK Biologicals
Oliver Wilbert,
Senior Director, Merck-Serono
Nicholas Valiante,
Head of Immunology, Novartis
Jerome Galon,
Director of Research, INSERM
Sonia Quaratino,
Senior Medical Director, Merck-Serono
Athansios Papadopoulos,
Senior Medical Advisor, Novartis
Matthew Albert,
Director of Immunology, Institut Pasteur
Philip Ashton-Rickardt,
Chair in Immunology, Imperial College London
Karl-Josef Kallen,
Chief Scientific Officer, CureVac
Eric Leire,
CEO, DanDrit Biotech
Christian Ottensmeier,
Professor in Experimental Cancer Medicine, University of Southampton
Rohit Lal,
Consultant Oncologist, Guy's Hospital

 



Search Calendar
Banner
http://www.timtec.net
http://www.zelinsky.com
FacebookMySpaceTwitterDiggDeliciousStumbleuponGoogle BookmarksRedditNewsvineTechnoratiLinkedinMixxRSS Feed

Upcoming Events

View full calendar